Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    An updated site revision tag is visible (Revision: v3.4.2), and the previous funding notice and earlier revision tag (v3.4.1) have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:40:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:38:42.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary is now shown on the page. Metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.3.4 and removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:17:26.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:54:30.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Minor update to the study page indicating a revision from v3.3.1 to v3.3.2; no substantive changes to study design, inclusion criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:25:29.000Z thumbnail image

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.